This HTML5 document contains 110 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q74317109
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel наукова стаття, опублікована в липні 2000 im Juli 2000 veröffentlichter wissenschaftlicher Artikel scientific article published on 01 July 2000 artículu científicu espublizáu en xunetu de 2000
p:P577
wds:Q74317109-157BBEF1-742C-42BB-9B59-17FC9A023C03
wdt:P577
2000-07-01T00:00:00Z
p:P2860
wds:Q74317109-09238882-0F5F-4259-89FE-10D5BAAF1A6E wds:Q74317109-09FAE1DD-D460-4121-8EEC-DE61A6C98DC0 wds:Q74317109-0D9C2B9B-AD42-4AFE-AA23-BEA8154A375B wds:Q74317109-D7221198-33F5-4BAB-95E7-41D22DCD26DD wds:Q74317109-D8A7F3F7-CC92-4BA6-9466-E80ECFBEE696 wds:Q74317109-E281EA4D-8C3A-4BB8-96FE-E7F269203131 wds:Q74317109-E69672B4-B008-464A-B76D-4958C53A72B1 wds:Q74317109-EA8B5A88-6422-49E5-B097-BC36B5370192 wds:Q74317109-ED38F4D6-C311-4083-AA5F-9DD2BF8267C5 wds:Q74317109-F5CD4E2E-9893-4BCD-A07C-2949A81AF783 wds:Q74317109-F7D7B38C-7E32-4405-9A94-D0F6CB19C1C5 wds:Q74317109-F818A9E8-A596-4234-994D-FE232801E871 wds:Q74317109-86F20011-5327-45AF-B410-6DA4A7ABA549 wds:Q74317109-8F8F3B1D-1D74-4057-8002-A0E8D6907A78 wds:Q74317109-95BE648B-0A7B-44BD-97F9-03212EC1D5BB wds:Q74317109-ADD22FBA-8282-4BEF-BF90-8998DE3E1972 wds:Q74317109-B0A9C52D-EAEC-432E-95BF-1E100A707774 wds:Q74317109-B49AA018-7374-4BAF-856C-6ED8E67515A2 wds:Q74317109-C0B66B4C-9687-4ADE-85B0-7F12CA812002 wds:Q74317109-C447E98D-0F4C-4677-9B36-55A5E06AACC1 wds:Q74317109-CAC108B7-C04E-4EB8-B4FD-2BB894633F16 wds:Q74317109-D4ED843B-3C2C-4C9C-8AB8-C85EBF6D2D74 wds:Q74317109-0F0C649B-3682-41DA-B35C-81E0CE500CD3 wds:Q74317109-132291AF-F833-4D05-BE19-9CA992F9ECBC wds:Q74317109-15CE969D-A88C-414D-9B5F-C0F70FC50E81 wds:Q74317109-2F0A55E5-4BC5-4A46-B74C-88211C7D12D0 wds:Q74317109-2F26B335-10C9-477E-A988-7189F7ECFE27 wds:Q74317109-32C92757-A9C8-4406-85F7-A0803809E01C wds:Q74317109-474E0F1D-440A-4EC5-9DD0-E2685CDFE2ED wds:Q74317109-54AAFC79-92C8-4DC1-AA7E-57F78EB489CC wds:Q74317109-5A51C7DA-CFFA-4B48-B8CA-31D93EBD34C2 wds:Q74317109-747AD6D1-D8FF-42ED-B35E-C68868A1A470
wdt:P2860
wd:Q73951463 wd:Q71591037 wd:Q42558212 wd:Q77318990 wd:Q35605782 wd:Q74469542 wd:Q35766675 wd:Q35994833 wd:Q73833058 wd:Q47388492 wd:Q54148277 wd:Q39776974 wd:Q71149922 wd:Q45109396 wd:Q72210816 wd:Q71974440 wd:Q77299992 wd:Q67476724 wd:Q71512149 wd:Q71565368 wd:Q47398372 wd:Q58363894 wd:Q28581981 wd:Q72250799 wd:Q34378188 wd:Q48393204 wd:Q73944468 wd:Q72080095 wd:Q59573861 wd:Q35604343 wd:Q43420596 wd:Q36678027
p:P2093
wds:Q74317109-72183BA1-8C8D-4DC2-B242-089DB04E616C wds:Q74317109-6A98917C-62FC-4510-BB83-059D9A035B71 wds:Q74317109-38ADBA1A-10DC-4656-85C3-0D9D0C46DC65 wds:Q74317109-AC5280F3-2DEB-4BAA-8F59-D3CE9529CA2A wds:Q74317109-7E954CBB-C0A7-48F6-B79E-36718E61D56F wds:Q74317109-C88CDFEF-A7AE-4BD6-A373-229FDFB36E7C wds:Q74317109-E62E2816-3498-4D5C-ACC4-294894B46222
wdt:P2093
Joles JA Verhagen AM Boer P Gröne H Hohbach J Braam B Koomans HA
rdfs:label
Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition
skos:prefLabel
Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition
schema:name
Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition
p:P1476
wds:Q74317109-7CD8B37F-CC72-4CAE-A3BF-1DBFCF7F16A8
wdt:P1476
Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition
p:P304
wds:Q74317109-E3C1C126-80DA-4BFA-87F1-6856912C3565
wdt:P304
239-247
p:P31
wds:Q74317109-0E315FCC-1B06-4934-AF76-81B286129500
wdt:P31
wd:Q13442814
p:P698
wds:Q74317109-105A6101-AAB2-48BD-84B3-774E90E32D63
wdtn:P698
n12:10988340
wdt:P698
10988340
p:P1433
wds:Q74317109-05101BDB-C837-45C1-9733-138106DB052C
wdt:P1433
wd:Q1376712
p:P433
wds:Q74317109-AF3C78AE-3BD8-48FA-803C-3707DE52C020
p:P478
wds:Q74317109-09CEBEBE-291C-4878-AA1E-13614D77A268
wdt:P433
2-3
wdt:P478
400
p:P356
wds:Q74317109-99CB8226-537B-4721-B8F6-08B24A4FBE10
wdtn:P356
n11:S0014-2999(00)00384-8
wdt:P356
10.1016/S0014-2999(00)00384-8